AleAnna (NASDAQ:ANNA) and BetterLife Pharma (OTCMKTS:BETRF) Financial Analysis

AleAnna (NASDAQ:ANNA) and BetterLife Pharma (OTCMKTS:BETRF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Insider & Institutional Ownership

38.1% of AleAnna shares are owned by institutional investors. Comparatively, 0.0% of BetterLife Pharma shares are owned by institutional investors. 42.9% of AleAnna shares are owned by company insiders. Comparatively, 34.8% of BetterLife Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and target prices for AleAnna and BetterLife Pharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AleAnna	1	0	0	0	1.00
BetterLife Pharma	0	0	0	0	0.00

Valuation & Earnings

This table compares AleAnna and BetterLife Pharma”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AleAnna	$25.04 million	9.13	$1.80 million	$0.04	85.75
BetterLife Pharma	N/A	N/A	-$2.55 million	N/A	N/A

AleAnna has higher revenue and earnings than BetterLife Pharma.

Volatility and Risk

AleAnna has a beta of -1.59, suggesting that its share price is 259% less volatile than the S&P 500. Comparatively, BetterLife Pharma has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

Profitability

This table compares AleAnna and BetterLife Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AleAnna	17.43%	10.42%	6.06%
BetterLife Pharma	N/A	N/A	-764.44%

Summary

AleAnna beats BetterLife Pharma on 8 of the 9 factors compared between the two stocks.

About AleAnna

AleAnna, Inc. engages in oil and gas exploration and production activities. It focuses on Italy’s natural gas reserves and developing renewable energy solutions. The company was founded in 2007 and is headquartered in Dallas, TX.

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.